News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gene Bridges GmbH Licenses Red/ET Recombineering to Novozymes A/S (NZYMb.CO)


4/21/2008 9:21:14 AM

HEIDELBERG, Germany--(BUSINESS WIRE)--Gene Bridges GmbH, the recombineering company, today announced that Novozymes has completed a commercial license agreement for the use of the Red/ET recombination technology from Gene Bridges.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES